Skip to main content
Top
Published in: Journal of Community Health 6/2013

01-12-2013 | Original Paper

HPV Vaccination and Sexual Behavior in a Community College Sample

Authors: Erica Marchand, Beth A. Glenn, Roshan Bastani

Published in: Journal of Community Health | Issue 6/2013

Login to get access

Abstract

Many US parents are concerned that vaccinating daughters against human papillomavirus (HPV) will communicate implicit approval for sexual activity and be associated with early or risky sexual behavior (Scarinci et al. in J Womens Health 16(8):1224–1233, 2007; Schuler et al. in Sex Transm Infect 87:349–353, 2011) [7, 8]. The aims of this study were to understand (a) whether the HPV vaccine was associated with risky sexual behavior among a diverse sample of female adolescents and young adults, and (b) to better understand the chronology of HPV vaccination and sexual behavior. An anonymous web-based survey was used to collect data from 114 female community college students. T test and Chi square analyses were used to compare vaccinated and unvaccinated groups on age at first intercourse and proportion who had ever had sexual intercourse. Linear multiple regression was used to predict frequency of condom use and number of sexual partners in the past year, using vaccination status and demographic factors as predictors. About 38 % reported receiving at least one dose of the HPV vaccine. Many of those vaccinated (45 %) received the vaccine after having initiated sexual activity. The proportion of women who were sexually experienced did not differ by HPV vaccine status, nor did age at first intercourse, number of partners in the past year, or frequency of condom use. Current findings suggest that HPV vaccination is not associated with riskier sexual activity for the young women in this sample. Adolescents and their parents may benefit from education about the need to receive the HPV vaccine before onset of sexual activity.
Literature
1.
go back to reference Romanowski, B., de Borba, P. C., Naud, P. S., et al. (2009). Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: Analysis of a randomized placebo-controlled trial up to 6.4 years. Lancet, 374, 1975–1985.PubMedCrossRef Romanowski, B., de Borba, P. C., Naud, P. S., et al. (2009). Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: Analysis of a randomized placebo-controlled trial up to 6.4 years. Lancet, 374, 1975–1985.PubMedCrossRef
2.
go back to reference Villa, L. L., Costa, R. L. R., Petta, C. A., et al. (2006). High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. British Journal of Cancer, 95, 1459–1466.PubMedCrossRef Villa, L. L., Costa, R. L. R., Petta, C. A., et al. (2006). High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. British Journal of Cancer, 95, 1459–1466.PubMedCrossRef
3.
go back to reference CDC. (2011). Recommended adult immunization schedule: United States, 2011. MMWR, 60(4), 1–4. CDC. (2011). Recommended adult immunization schedule: United States, 2011. MMWR, 60(4), 1–4.
4.
go back to reference CDC. (2011). Recommended immunization schedules for persons aged 0 through 18 years: United States, 2011. MMWR, 60(5), 1–4. CDC. (2011). Recommended immunization schedules for persons aged 0 through 18 years: United States, 2011. MMWR, 60(5), 1–4.
5.
go back to reference CDC. (2013). Adult vaccination coverage: United States, 2011. MMWR, 62(4), 66–72. CDC. (2013). Adult vaccination coverage: United States, 2011. MMWR, 62(4), 66–72.
6.
go back to reference CDC. (2012). National and state vaccination coverage among adolescents aged 13 through 17 years: United States, 2011. MMWR, 61(34), 671–677. CDC. (2012). National and state vaccination coverage among adolescents aged 13 through 17 years: United States, 2011. MMWR, 61(34), 671–677.
7.
go back to reference Scarinci, I. C., Garcès-Palacio, I. C., & Partridge, E. E. (2007). An examination of acceptability of HPV vaccination among African American women and Latina immigrants. Journal of Women’s Health, 16(8), 1224–1233.PubMedCrossRef Scarinci, I. C., Garcès-Palacio, I. C., & Partridge, E. E. (2007). An examination of acceptability of HPV vaccination among African American women and Latina immigrants. Journal of Women’s Health, 16(8), 1224–1233.PubMedCrossRef
8.
go back to reference Schuler, C. L., Reiter, P. L., Smith, J. S., et al. (2011). Human papillomavirus vaccine and behavioural disinhibition. Sexually Transmitted Infection, 87, 349–353.CrossRef Schuler, C. L., Reiter, P. L., Smith, J. S., et al. (2011). Human papillomavirus vaccine and behavioural disinhibition. Sexually Transmitted Infection, 87, 349–353.CrossRef
9.
go back to reference Mullins, T. L. K., Zimet, G. D., Rosenthal, S. L., et al. (2012). Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination. Archives of Pediatric and Adolescent Medicine, 166, 82–88.CrossRef Mullins, T. L. K., Zimet, G. D., Rosenthal, S. L., et al. (2012). Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination. Archives of Pediatric and Adolescent Medicine, 166, 82–88.CrossRef
10.
go back to reference Bednarczyk, R. A., Davis, R., Ault, K., Orenstein, W., & Omer, S. B. (2010). Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds. Pediatrics, 130, 798–805.CrossRef Bednarczyk, R. A., Davis, R., Ault, K., Orenstein, W., & Omer, S. B. (2010). Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds. Pediatrics, 130, 798–805.CrossRef
11.
go back to reference Liddon, N. C., Leichliter, J. S., & Markowitz, L. E. (2012). Human papillomavirus vaccine and sexual behavior among adolescent and young women. American Journal of Preventive Medicine, 42, 44–52.PubMedCrossRef Liddon, N. C., Leichliter, J. S., & Markowitz, L. E. (2012). Human papillomavirus vaccine and sexual behavior among adolescent and young women. American Journal of Preventive Medicine, 42, 44–52.PubMedCrossRef
12.
go back to reference Marchand, E., Glenn, B., & Bastani, R. (2012). Low HPV vaccine coverage among female community college students. Journal of Community Health, 37, 1136–1144.PubMedCrossRef Marchand, E., Glenn, B., & Bastani, R. (2012). Low HPV vaccine coverage among female community college students. Journal of Community Health, 37, 1136–1144.PubMedCrossRef
13.
go back to reference Allen, J., Othus, M., Shelton, R. C., et al. (2010). Parental decision making about the HPV vaccine. Cancer Epidemiology, Biomarkers and Prevention, 19, 2187–2198.PubMedCrossRef Allen, J., Othus, M., Shelton, R. C., et al. (2010). Parental decision making about the HPV vaccine. Cancer Epidemiology, Biomarkers and Prevention, 19, 2187–2198.PubMedCrossRef
14.
go back to reference Bastani, R., Glenn, B., Tsui, J., et al. (2011). Understanding sub-optimal HPV vaccine uptake among ethnic minority girls. Cancer Epidemiology, Biomarkers and Prevention, 20, 1463–1472.PubMedCrossRef Bastani, R., Glenn, B., Tsui, J., et al. (2011). Understanding sub-optimal HPV vaccine uptake among ethnic minority girls. Cancer Epidemiology, Biomarkers and Prevention, 20, 1463–1472.PubMedCrossRef
15.
go back to reference Roberts, M., Gerrard, M., Reimer, R., & Gibbons, F. (2010). Mother-daughter communication and human papillomavirus vaccine uptake by college students. Pediatrics, 125, 982–989.PubMedCrossRef Roberts, M., Gerrard, M., Reimer, R., & Gibbons, F. (2010). Mother-daughter communication and human papillomavirus vaccine uptake by college students. Pediatrics, 125, 982–989.PubMedCrossRef
16.
go back to reference Metzler, C. W., Noell, J., & Biglan, A. (1992). The validation of a construct of high-risk sexual behavior in heterosexual adolescents. Journal of Adolescent Research, 7, 233–249.CrossRef Metzler, C. W., Noell, J., & Biglan, A. (1992). The validation of a construct of high-risk sexual behavior in heterosexual adolescents. Journal of Adolescent Research, 7, 233–249.CrossRef
17.
go back to reference Safran, D. G., Kosinski, M., Tarlov, A. R., et al. (1998). The primary care assessment survey: Tests of data quality and measurement performance. Medical Care, 36, 728–739.PubMedCrossRef Safran, D. G., Kosinski, M., Tarlov, A. R., et al. (1998). The primary care assessment survey: Tests of data quality and measurement performance. Medical Care, 36, 728–739.PubMedCrossRef
18.
go back to reference Veldhuijze, N. J., Snijders, P. J. F., Reiss, P., Meijer, C. J. L. M., & van de Wijgert, J. H. H. M. (2010). Factors affecting transmission of mucosal human papillomavirus. Lancet Infectious Disease, 10, 862–874.CrossRef Veldhuijze, N. J., Snijders, P. J. F., Reiss, P., Meijer, C. J. L. M., & van de Wijgert, J. H. H. M. (2010). Factors affecting transmission of mucosal human papillomavirus. Lancet Infectious Disease, 10, 862–874.CrossRef
19.
go back to reference Forhan, S. E., Gottlieb, S. L., Sternberg, M. R., et al. (2009). Prevalence of sexually transmitted infections among female adolescents aged 14–19 in the United States. Pediatrics, 124, 1505–1512.PubMedCrossRef Forhan, S. E., Gottlieb, S. L., Sternberg, M. R., et al. (2009). Prevalence of sexually transmitted infections among female adolescents aged 14–19 in the United States. Pediatrics, 124, 1505–1512.PubMedCrossRef
20.
go back to reference Stupiansky, N. W., Zimet, G. D., Cummings, T., Fortenberry, J. D., & Shew, M. (2012). Accuracy of self-reported human papillomavirus vaccine receipt among adolescent girls and their mothers. Journal of Adolescent Health, 50, 103–105.PubMedCrossRef Stupiansky, N. W., Zimet, G. D., Cummings, T., Fortenberry, J. D., & Shew, M. (2012). Accuracy of self-reported human papillomavirus vaccine receipt among adolescent girls and their mothers. Journal of Adolescent Health, 50, 103–105.PubMedCrossRef
Metadata
Title
HPV Vaccination and Sexual Behavior in a Community College Sample
Authors
Erica Marchand
Beth A. Glenn
Roshan Bastani
Publication date
01-12-2013
Publisher
Springer US
Published in
Journal of Community Health / Issue 6/2013
Print ISSN: 0094-5145
Electronic ISSN: 1573-3610
DOI
https://doi.org/10.1007/s10900-013-9710-0

Other articles of this Issue 6/2013

Journal of Community Health 6/2013 Go to the issue